Consolidated Statements of Equity (USD $) In Millions, except Share data, unless otherwise specified	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accumulated Translation Adjustment [Member]	Total
Balance at Jun. 30, 2011	$ 99.8	$ 0.8	$ (1.0)	$ (50.7)	$ 32.5	$ 81.4
Balance (in Shares) at Jun. 30, 2011	181,417,556		(1,311,034)
Comprehensive loss
Exchange differences on translation of foreign operations					(3.0)	(3.0)
Net loss				(19.2)		(19.2)
Total Comprehensive income						(22.2)
New shares issued on exercise of options	0.6	(0.6)
New shares issued on exercise of options (in Shares)	932,760
Purchase of treasury shares			(0.4)			(0.4)
Purchase of treasury shares (in Shares)			(505,144)
Share-based compensation		0.5				0.5
Balance at Jun. 30, 2012	100.4	0.7	(1.4)	(69.9)	29.5	59.3
Balance (in Shares) at Jun. 30, 2012	182,350,316		(1,816,178)
Comprehensive loss
Exchange differences on translation of foreign operations					(4.2)	(4.2)
Net loss				(8.9)		(8.9)
Total Comprehensive income						(13.1)
New shares issued on exercise of options	0.4	(0.4)
New shares issued on exercise of options (in Shares)	413,335
New shares issued on vesting of options on merger	1.1	(1.1)
New shares issued on vesting of options on merger (in Shares)	4,639,104
Acquisition of Nabi Biopharmaceuticals	(98.5)	233.4	(115.7)			19.2
Acquisition of Nabi Biopharmaceuticals (in Shares)	(153,398,048)		(4,051,183)
Retirement of treasury shares	(0.6)	(116.5)	117.1
Retirement of treasury shares (in Shares)	(5,867,361)		5,867,361
Restricted stock, Shares (in Shares)	214,983
Retirement of common stock (in Shares)	(3)
Share-based compensation		2.6				2.6
Balance at Jun. 30, 2013	2.8	118.7		(78.8)	25.3	68.0
Balance (in Shares) at Jun. 30, 2013	28,352,326					28,352,326
Comprehensive loss
Exchange differences on translation of foreign operations					1.5	1.5
Net loss				(11.0)		(11.0)
Total Comprehensive income						(9.5)
Common stock issued	0.7	26.1				26.8
Common stock issued (in Shares)	6,685,985
Restricted stock		0.2				0.2
Restricted stock, Shares (in Shares)	62,650
Share-based compensation		1.4				1.4
Balance at Jun. 30, 2014	$ 3.5	$ 146.4		$ (89.8)	$ 26.8	$ 86.9
Balance (in Shares) at Jun. 30, 2014	35,100,961					35,100,961